WHO Home Page

Office of the Director-General

World Health Organization
Organisation mondiale de la Santé

UPDATED: Mon Feb 18 16:59:04 2002

Dr. Gro Harlem Brundtland        
Director-General
World Health Organization

European Commission, Brussels,
28 September 2000

   

High Level Round Table on Accelerated Action Targeted at Major Communicable Diseases within the context of Poverty Reduction

Opening Statement

President Prodi,
Prime Minister Mocumbi,
Members of the European Parliament,
Commissioners,
Ladies and Gentlemen,

It gives me great pleasure to address you at the start of this important meeting.

I congratulate President Prodi and his colleagues. The EC’s policy framework is a swift and decisive response to the international call for action against communicable diseases. Today, the Commission has assembled stakeholders from around the world to discuss the way forward - as we move from policy to implementation. WHO is proud to be a co-sponsor of this Round Table meeting.

The landscape in which we work is changing. We meet at a time of unprecedented international support for reducing poverty. And at a time when health takes its rightful place at centre stage in the development arena. We know that poor people suffer disproportionately from the ravages of communicable diseases. We know too that HIV/AIDS, TB and malaria are themselves major causes of poverty. The success or failure of our collective response to these threats is critical. It holds the key to the economic and physical security - not just of individuals and communities - but of nations and continents.

The problems we face are daunting. The costs will be high. But the price of failure will be even greater.

Economics is just one part of the picture. But the emerging image is clear. Current estimates suggest that an additional $1 billion dollars annually will be required to combat malaria effectively. But the annual pay-off from this investment could be a $12 billion boost to the combined GDP of countries in sub-Saharan Africa. The situation with TB is similar. Another billion dollars annually spent on drugs - linked to work on health systems - could result in a 50% drop in mortality over the next five years. With HIV/AIDS, we need even more. Sums in the order of $2.5 billion dollars annually are needed for prevention alone. Add the cost of care, and the figures rise dramatically. A huge demand, perhaps, but the cost of inaction is higher. We are already seeing the penalty in terms of reductions in GDP of up to 1% per year in the worst affected countries.

The EC’s Communication signposts the way forward and highlights the challenges we face.

We can do more with the tools and technologies that exist today - if we use our imagination, our creativity - and if we are prepared to learn from others. There are countries - and some of them are around this table - that can show the world the way. They have reduced HIV infection rates - by up to 80% in some cases - and they have reduced deaths due to TB and malaria. These countries are pathfinders. Their leaders have given strong political support. They have used all effective channels to ensure that poor people have better access to information and services. Our challenge is to ensure that the lessons they have learned are applied as widely as possible.

To increase peoples access to care, we have to examine ways in which drugs and other supplies can be made more affordable to poor populations. We welcome the clear and comprehensive analysis of factors influencing costs that we find in the Communication. Governments around the world face tough choices when it comes to the financing and provision of care. These decisions are their responsibility alone. It is critical, however, that they are fully aware of their options. This means having information to help in selecting the right products - for promoting generic competition - for ensuring access to life-saving patented products - for reducing the costs associated with taxes and tariffs - and for securing long term financial sustainability. The challenge is to agree on enabling global actions which can catalyse and support countries effort.

We must invest in the future - for new drugs, new vaccines and new diagnostic tools. Our challenge is to create the incentives - and the right kind of economic environment - that will give priority to the diseases which create and perpetuate poverty. Research and development is a critical part of the strategy.

Mr President,

Communicable diseases are the next bridgehead in the campaign to secure the livelihood of billions throughout the world.

We have to work together. No one government or agency can succeed alone. We need new ways of working.

We will not succeed by looking back. We must build on promising approaches such as the Comprehensive Development Framework. We must secure the place of better health in Poverty Reduction Strategies. But we must - above all else - ensure that we get results – results that will transform the lives of poor people.

Health is key to development, and successful development requires collaboration across traditional boundaries. We have to learn to think beyond our sectoral departments. The policy framework prepared by the European Commission gives us the right direction. It heralds a new way of working - between sectors, between development partners, and between national governments and the international community. WHO is committed to helping it succeed.

Thank you.

Return to Director-General's main page